Edition:
United States

Invesco Ltd (IVZ.N)

IVZ.N on New York Stock Exchange

29.18USD
4:04pm EDT
Change (% chg)

$0.26 (+0.90%)
Prev Close
$28.92
Open
$28.78
Day's High
$29.24
Day's Low
$28.67
Volume
1,317,262
Avg. Vol
1,271,866
52-wk High
$39.48
52-wk Low
$23.02

IVZ.N

Chart for IVZ.N

About

Invesco Ltd. (Invesco) is an independent global investment management company. The Company provides a range of investment capabilities and outcomes, which are delivered through a diverse set of investment vehicles, to help clients achieve their investment objectives. It operates in the investment management segment. The Company... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $12,067.34
Shares Outstanding(Mil.): 417.27
Dividend: 0.28
Yield (%): 3.87

Financials

  IVZ.N Industry Sector
P/E (TTM): 14.12 86.23 18.55
EPS (TTM): 2.05 -- --
ROI: 5.69 5.62 0.47
ROE: 10.88 2.88 17.74

BRIEF-Invesco Ltd Q2 adjusted earnings per share $0.56

* Total assets under management (AUM) at June 30, 2016, were $779.6 billion, an increase of $8.1 billion during Q2

Jul 28 2016

BRIEF-Invesco preliminary June month-end AUM of $779.6 bln, a decrease of 1.5 pct month over month

* Preliminary june month-end assets under management (aum) of $779.6 billion, a decrease of 1.5% month over month

Jul 12 2016

Sovereign investors' M&A deals fall 26 percent by value in second quarter

LONDON Sovereign investors, including wealth funds, made $14.1 billion worth of acquisitions in the second quarter, down 26 percent from the first three months of the year but underpinned by a rebound in real estate deals.

Jul 08 2016

Sovereign investors' M&A deals fall 26 pct by value in second quarter

LONDON, July 8 Sovereign investors, including wealth funds, made $14.1 billion worth of acquisitions in the second quarter, down 26 percent from the first three months of the year but underpinned by a rebound in real estate deals.

Jul 08 2016

BRIEF-Invesco ltd announces accelerated share repurchase program

* Invesco Ltd provides update on UK and continental Europe business; announces accelerated share repurchase program

Jun 30 2016

Cat allergy flop torpedoes high-profile UK biotech Circassia

Circassia Pharmaceuticals lost nearly two-thirds of its value on Monday as its experimental cat allergy treatment failed in a late-stage trial, dealing a major blow to the high-profile British biotech company.

Jun 20 2016

UPDATE 2-Cat allergy flop torpedoes high-profile UK biotech Circassia

* Treatment fails to show benefit over big placebo effect (Adds CEO interview, details on investors, updates shares)

Jun 20 2016

BRIEF-Invesco says May preliminary month-end AUM of $791.1 bln

* Invesco Ltd says reported May preliminary month-end assets under management of $791.1 billion , an increase of 0.9% month over month

Jun 09 2016

MOVES-Invesco names consultant relations director

June 6 Investment management company Invesco named Chris Evans investment consultant relations director in its EMEA institutional team.

Jun 06 2016

Invesco: long-term U.S. bond yields unlikely to rise even if Fed hikes

TOKYO Even though the Federal Reserve is expected to raise interest rates, long-term U.S. bond yields are unlikely to rise due to China's slowdown and negative rates in Japan and Europe, the top fund manager of Invesco Ltd's $240 bln global bond funds said.

May 27 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.